By: Michael Ip, MD, Martin David Harp
At ARVO 2026, Michael Ip, MD, presented findings from a large-scale analysis of OCT biomarkers in patients with diabetic macular edema (DME), leveraging the robust DRCR Retina Network Protocol T dataset.
The study examined whether granular OCT features could predict visual and anatomical outcomes following anti-VEGF therapy. Ophthalmology Times spoke with Dr. Ip about the key takeaways and what they mean for clinical practice.